Depression Clinical Trials in Chicago

Showing 241-260 of 271 trials

An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression

NCT00587639

The objective of this investigation is to examine the safety and feasibility of a series of repetitive transcranial magnetic stimulation (rTMS) treatments (10 Hertz \[Hz\]; Left Dorsolateral Prefrontal Cortex), with a Neuronetics Model 2100 Therapy System as adjuvant treatment for depression in adolescent subjects.

Depression

Mayo Clinic8 participantsStarted May 2007

Chicago, Illinois, United States • Rochester, Minnesota, United States • Dallas, Texas, United States

COMPLETED2.2 miles

EEG Biomarkers for Predicting Response to Antidepressant Therapy

NCT00289523

The purpose of this study is to evaluate the potential early EEG predictors of an individual's response to treatment with antidepressant medications. Objectives: * Prospectively confirm accuracy of current EEG biomarker algorithm * Determine preferred clinical intervention for subjects with negative indicator * Identify predictors of worsening suicide ideation

Major Depressive Disorder

Medtronic - MITG375 participantsStarted Jan 2006

Los Angeles, California, United States • Los Angeles, California, United States • San Diego, California, United States +7 more locations

COMPLETEDPhase 32.2 miles

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

NCT01309542

The study evaluated the long-term safety of Desvenlafaxine Succinate (DVS) Slow Release (SR) during open-label treatment in adult outpatients who had a primary diagnosis of major depressive disorder (MDD). The study also evaluated the long-term response of subjects receiving DVS SR for clinical global evaluation, functionality, general well-being, pain, and absence of depressive symptoms (remission).

Major Depressive Disorder

Pfizer1,403 participantsStarted Aug 2003

Birmingham, Alabama, United States • Mesa, Arizona, United States • Peoria, Arizona, United States +114 more locations

An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression

EEG Biomarkers for Predicting Response to Antidepressant Therapy

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

Depression Trials in Other Cities

Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention

A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HCl

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

Effects of Antidepressants on Sexual Functioning

A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

Escitalopram in Adult Patients With Major Depressive Disorder

Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

The Clinic Treatment Project

Other Conditions in Chicago